For filings with the FSA include the annex |
TR-1: Notifications of Major Interests in Shares |
1. Identity of the issuer or the underlying issuer of existing |
||
Proteome Sciences plc |
||
2. Reason for notification |
[Yes/No] |
|
An acquisition or disposal of voting rights |
Yes |
|
An acquisition or disposal of financial instruments which may result in the |
No |
|
An event changing the breakdown of voting rights |
No |
|
Other (please specify): |
No |
|
3. Full name of person(s) subject to notification |
Sanofi-Aventis Deutschland GmbH |
|
4. Full name of shareholder(s) (if different from 3): |
|
|
5. Date of transaction (and date on which the |
17 March 2009 |
|
6. Date on which issuer notified: |
18 March 2009 |
|
7. Threshold(s) that is/are crossed or reached: |
9% |
8: Notified Details |
A: Voting rights attached to shares |
Class/type of |
Situation previous to |
Resulting situation after |
|||||
If possible use |
Number of shares |
Number of |
Number of shares |
Number of |
Percentage of |
||
|
|
|
|
Direct |
Indirect |
Direct |
Indirect |
GB0003104196 |
12,286,187 |
12,286,187 |
10,859,124 |
10,859,124 |
- |
8.18% |
- |
|
|
|
|
|
|
|
|
B: Financial Instruments |
Resulting situation after the triggering transaction |
Type of financial instrument |
Expiration date |
Exercise/ conversion period/date |
No. of voting rights that may be acquired (if the instrument exercised/converted) |
Percentage of voting rights |
N/A |
N/A |
N/A |
N/A |
N/A |
|
|
|
|
|
Total (A+B) |
Number of voting rights |
Percentage of voting rights |
10,859,124 |
8.18% |
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable: |
|
Proxy Voting: |
|
10. Name of proxy holder: |
|
11. Number of voting rights proxy |
|
12. Date on which proxy holder will |
|
13. Additional information: |
|
14 Contact name: |
Juergen Blieke or Reiner May |
15. Contact telephone name: |
0049 69 305 4703 or 0049 69 305 80202 |
For notes on how to complete form TR-1 please see the FSA website.